MicroTransponder
Innovative neurostimulation therapies empowering neurological health since 2007.
Innovative neurostimulation therapies empowering neurological health since 2007.
MicroTransponder, a Texas-based medical device company, has been pioneering innovative neurostimulation therapies since 2007. The company specializes in developing and commercializing neurostimulation devices to address neurological diseases. Among their flagship therapies are the Paired VNS System and a wireless neurostimulation system designed to tackle chronic pain, post-stroke upper limb mobility issues, and various neurological conditions. Their efforts have culminated in a Series B investment in May 31, 2012, with Green Park & Golf Ventures as the lead investor. MicroTransponder's work empowers healthcare professionals to effectively manage and treat challenging neurological health concerns, placing them at the forefront of the Health Care, Manufacturing, and Medical Devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | Unknown | 1 |
|
31 May 2012 |
| Venture Round | $2.68M | - | 16 Sep 2010 |
No recent news or press coverage available for MicroTransponder.
We care about your data, and we'd love to use cookies make your experience better.
